Headlands Research Acquires Pharmasite Research
February 29, 2024
Headlands Research, a multinational network of clinical trial sites, has acquired Pharmasite Research, a Maryland-based clinical trial site focused on mental illness and central nervous system (CNS) disorders. The deal expands Headlands' therapeutic capabilities in mental health and extends its site network's reach in the Mid-Atlantic, bringing the network to 18 sites across the United States and Canada.
- Buyers
- Headlands Research
- Targets
- Pharmasite Research
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
THL Partners Acquires Headlands Research from KKR
August 16, 2025
Healthcare Services
THL Partners entered into a definitive agreement to acquire Headlands Research, a multinational network of clinical trial sites, from funds managed by KKR. The deal is intended to accelerate Headlands’ clinical trial site expansion and enhance its technology and centralized infrastructure for pharmaceutical and biotech sponsors.
-
Headlands Research Acquires Clinical Research Professionals (St. Louis)
October 12, 2023
Healthcare Services
Headlands Research has acquired Clinical Research Professionals, a St. Louis–area clinical research site, expanding Headlands' network and geographic reach. The acquisition adds experienced investigators and capabilities across therapeutic areas including gastroenterology, neurology, and vaccines, supporting increased participant recruitment and trial capacity.
-
Headlands Research Acquires Clinvest Research
May 4, 2023
Healthcare Services
Headlands Research, a multinational clinical trial site network, has acquired Clinvest Research, a Springfield, Missouri-based clinical research site that has conducted over 600 trials since 1996. The deal expands Headlands' chronic pain and endocrinology capabilities and increases participant access for trials in the United States.
-
Headlands Research Acquires Eastern Massachusetts Clinical Research Site
April 18, 2023
Healthcare Services
Headlands Research acquired an established clinical research site now operating as Headlands Research Eastern Massachusetts. The site — led by neurologist Dr. Donald Marks and specializing in neurodegenerative diseases such as Alzheimer’s and Parkinson’s — broadens Headlands’ neurology research capabilities and expands its clinical trial site network in Eastern Massachusetts.
-
Headlands Research Acquires Peninsula Research Associates
June 30, 2022
Healthcare Services
Headlands Research, a KKR-backed clinical trial site network based in San Francisco, acquired Peninsula Research Associates (PRA) of Rolling Hills, California. The undisclosed transaction expands Headlands' clinical research capabilities in allergy and asthma, pediatric studies and vaccine trials while extending its Southern California footprint.
-
Headlands Research Acquires Summit Research Network
May 13, 2021
Healthcare Services
Headlands Research, a KKR-backed clinical research site organization based in San Francisco, has acquired Summit Research Network in Portland, Oregon, expanding Headlands' site footprint and expertise in neurology, psychiatry and memory-health research. The deal grows Headlands' global network to 15 clinical trial sites and accompanies the launch of a fourth Horizons site in Scottsdale, Arizona.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.